Navigation Links
NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Date:9/21/2007

ited to, past results of clinical trials may not be indicative of future clinical trials results; NeurogesX' product candidate may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; physician or patient reluctance to use NGX-4010, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in clinical development, obtaining regulatory approval, market acceptance and commercialization of NGX-4010 and the advantages of NGX-4010 over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
8. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- According to a new market research ... (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by ... to 2020", published by MarketsandMarkets, the Transfection Reagents and ... by 2020 with a CAGR of 7.2% from 2014 ... ables and 33 F igures ...
(Date:7/1/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nk3569/future_horizons ... "Future Horizons and Growth Strategies in the European ... Forecasts" report to their offering. ... Blood Banking Market 2015 is a new five-countrystrategic ... and potential market entrants identify and evaluate emerging ...
(Date:7/1/2015)... MARLBOROUGH, Mass. , July 1, 2015 Boston ... call discussing financial results and business highlights for the second ... at 8 a.m. ET. The call will be ... officer, and Dan Brennan , executive vice president and ... conference call will be available via the Boston Scientific website. ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
... TechniScan (OTC Bulletin Board: TSNI ), a ... an automated 3D breast ultrasound imaging system, announced today that ... with Austin, Texas-based Womens3D. These agreements follow ... January 2011 in which they agreed to jointly develop a ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... company,s president and chief executive officer, is scheduled ... Markets Healthcare ConferenceWednesday, March 2, 20119:00 a.m. Eastern ... Health Care Conference Tuesday, March 8, 201111:00 a.m. ...
Cached Medicine Technology:Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company 2
(Date:7/1/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership solutions firm dedicated ... officer recruitment for Capital Health in Pennington, N.J. One of the ... recently placed more than 1,000 healthcare executives into organizations. , Capital Health is ...
(Date:7/1/2015)... ... July 01, 2015 , ... Research published in the journal JAMA Ophthamology ... eyesight was just as accurate as those from standard paper-based charts and illuminated vision ... responsible for the development of the test, which does not depend on traditional familiarity ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... Northbound team as Director of Referral Relations. , Emily originally entered the ... where she designed and implemented unique academic curriculum for clients to engage in ...
(Date:7/1/2015)... , ... July 01, 2015 ... ... the communities of southeast Alabama, southwest Georgia and the Florida Panhandle, the ... as its primary secure text messaging and clinical communications workflow solution provider. ...
(Date:7/1/2015)... ... ... Foot and Ankle Specialists of the Mid-Atlantic, LLC (FASMA) podiatrists Kerry ... Family Wellness Day event at Centennial Park on June 7, 2015. The event ... workout demonstrations, and more. Drs. Becker and Friske educated attendees on common foot ...
Breaking Medicine News(10 mins):Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3
... Commonwealth University announced Wednesday it has received a $20 ... history from the National Institutes of Health to ... working to turn laboratory discoveries into treatments for patients. ... VCU the only academic health center in Virginia to ...
... Dennis Thompson HealthDay Reporter , TUESDAY, July 13 (HealthDay ... not be getting the help they need. Mental health experts ... in 10 children age 9 to 17 years old -- girls ... disorder, according to the U.S. Department of Health and Human Services. ...
... This release is available in French . ... promise as an effective anti-diabetic, according to a new study ... Yaound (Cameroun). Published in the journal Molecular Nutrition & ... of cashew tree products on diabetes, notably whether cashew extracts ...
... University of Texas great Colt McCoy is teaming up with ... to raise $50 million for a planned regional children,s hospital. ... and donors at Scott & White Hospital in Temple. ... Scott & White in April 2009, will be renovated into ...
... alcohol problems are finding comfort in speaking about their ... 1,910 people with any alcohol-related problems, 14.7 percent said ... University of Michigan Health System and Saint Louis University, ... from clergy also used professional services at some point; ...
... Today during the 88th General Session & Exhibition of ... presenting author J. Meyle, Justus Liebig University, Giessen, Germany, ... Infection and Immune Evasion of Oral Carcinomas." Meyle ... cancers and periodontal disease. They achieved results by infecting ...
Cached Medicine News:Health News:VCU first Virginia institution to join national network of academic research centers 2Health News:Mood Disorders Going Undetected in U.S. Children 2Health News:Mood Disorders Going Undetected in U.S. Children 3Health News:Colt McCoy teams with Scott & White to build children's hospital 2Health News:Individuals confess alcohol abuse to clergy 2
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... the first manufacturer to offer through-the-lens ... wearer. These next generation loupes feature ... ultra-lightweight design, and are multi-coated lens ... With SheerVision's proprietary SureFit system - ...
Medicine Products: